NA In Vivo Preclinical Brain Imaging Devices Market - Industry Trends and Forecast to 2034

Description

List of Tables

The North America in vivo preclinical brain imaging devices market is expected to reach USD 418,680.72 thousand by 2030 from USD 714,350.31 thousand in 2022, growing at a CAGR of 6.4 % in the forecast period of 2023 to 2030.

Market Segmentation

North America In Vivo Preclinical Brain Imaging Devices Market, By Imaging Modality Type (MRI, PET/SPECT, CT, Optical Miniscopes, 2Photon Confocal, US, NIR Fluorescence, OCT, Bioluminescence, and Others), Application (Drug Discovery, Disease Characterization, and Toxicology), Therapeutic Area (Alzheimer's Disease, Parkinson's Disease, Oncology, and Other Therapeutic Areas), Biological Variable (BOLD, Oxygenation, Blood Flow, Microvessels, Neuronal Activity, and Soft Tissue), Temporal Format of Use (Under an Hour, Many Hours, and Longitudinal) End User (Pharma-Inhouse, CRO, Academia, and Others), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030.

Overview of North America In Vivo Preclinical Brain Imaging Devices Market Dynamics

Driver
Rising prevalence of neurological disorder
Restraint
Ethical and regulatory consideration
Opportunity
Rising research and development activities

Market Players

The key market players operating in the North America in vivo preclinical brain imaging devices market are:

Bruker
PerkinElmer Inc.
FUJIFILM Corporation
Miltenyi Biotec
Charles River Laboratories.
Hologic, Inc.
LI-COR, Inc.
MILabs B.V.
TriFoil Imaging
Berthold Technologies GmbH & Co.KG
A14R
Aspect Imaging Ltd.
Cubresa Inc.
Mediso Ltd.
MR Solutions
Spectrum Instruments Imaging

1 INTRODUCTION 14

1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 OVERVIEW OF THE NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET 14
1.4 CURRENCY AND PRICING 15
1.5 LIMITATIONS 16
1.6 MARKETS COVERED 16

2 MARKET SEGMENTATION 18

2.1 MARKETS COVERED 18
2.2 GEOGRAPHICAL SCOPE 19
2.3 YEARS CONSIDERED FOR THE STUDY 20
2.4 DBMR TRIPOD DATA VALIDATION MODEL 21
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 24
2.6 MULTIVARIATE MODELLING 25
2.7 IMAGING MODALITY TYPE SEGMENT LIFELINE CURVE 25
2.8 MARKET END USER COVERAGE GRID 26
2.9 DBMR MARKET POSITION GRID 27
2.10 VENDOR SHARE ANALYSIS 29
2.11 SECONDARY SOURCES 30
2.12 ASSUMPTIONS 30

3 EXECUTIVE SUMMARY 31

4 PREMIUM INSIGHTS 34

4.1 PESTEL ANALYSIS 35
4.2 PORTR'S FIVE FORCES 36

5 REGULATORY FRAMEWORK 37

5.1 REGULATORY SCENARIO IN U.S. 37
5.2 REGULATORY SCENARIO IN AUSTRALIA 37
5.3 REGULATORY SCENARIO IN EUROPE 38
5.4 REGULATORY SCENARIO IN SOUTH AFRICA 38
5.5 REGULATORY SCENARIO IN BRAZIL 38

6 MARKET OVERVIEW 39

6.1 DRIVERS 41
- 6.1.1 RISING PREVALENCE OF NEUROLOGICAL DISORDERS 41
- 6.1.2 ADVANCEMENTS IN IMAGING TECHNIQUES USED IN BRAIN IMAGING 41
- 6.1.3 INCREASING ADOPTION OF IN-VIVO IMAGING SYSTEMS 42
6.2 RESTRAINTS 42
- 6.2.1 ETHICAL AND REGULATORY CONSIDERATIONS 42
- 6.2.2 HIGH COST ASSOCIATED WITH BRAIN IMAGING EQUIPMENT 42
6.3 OPPORTUNITIES 43
- 6.3.1 RISING STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS 43
- 6.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 43
6.4 CHALLENGES 44
- 6.4.1 LACK OF SKILLED PROFESSIONALS DUE TO TECHNOLOGY ADVANCEMENT 44
- 6.4.2 INTEGRATION OF IMAGING DEVICES WITH OTHER TECHNOLOGIES 45

7 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE 46

7.1 OVERVIEW 47
7.2 MRI 48
7.3 PET/SPECT 49
7.4 CT 49
7.5 OPTICAL MINISCOPES 50
7.6 2 PHOTON CONFOCAL 50
7.7 US 51
7.8 NIR FLUORESCENCE 51
7.9 OCT 52
7.10 BIOLUMINESCENCE 52
7.11 OTHERS 53

8 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION 54

8.1 OVERVIEW 55
8.2 DRUG DISCOVERY 56
- 8.2.1 PRECLINICAL STUDIES 57
- 8.2.2 EARLY DRUG DISCOVERY 57
- 8.2.3 CLINICAL DEVELOPMENT 57
- 8.2.4 POST MARKET MONITORING 57
- 8.2.5 DATA REVIEW 57
8.3 DISEASE CHARACTERIZATION 57
8.4 TOXICOLOGY 58

9 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA 59

9.1 OVERVIEW 60
9.2 ALZHEIMER'S DISEASE 61
9.3 PARKINSON'S DISEASE 62
9.4 ONCOLOGY 62
9.5 OTHER THERAPEUTIC AREAS 63

10 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 64

10.1 OVERVIEW 65
10.2 BOLD 66
10.3 OXYGENATION 67
10.4 BLOOD FLOW 67
10.5 MICROVESSELS 68
10.6 NEURONAL ACTIVITY 68
10.7 SOFT TISSUE 69

11 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE 70

11.1 OVERVIEW 71
11.2 UNDER AN HOUR 72
11.3 MANY HOURS 73
11.4 LONGITUDINAL 73

12 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER 74

12.1 OVERVIEW 75
12.2 PHARMA-INHOUSE 76
12.3 CRO 77
12.4 ACADEMIA 77
12.5 OTHERS 78

13 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION 79

13.1 NORTH AMERICA 80

14 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, COMPANY LANDSCAPE 89

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 89

15 SWOT ANALYSIS 90

16 COMPANY PROFILE 91

16.1 BRUKER 91
- 16.1.1 COMPANY SNAPSHOT 91
- 16.1.2 REVENUE ANALYSIS 91
- 16.1.3 COMPANY SHARE ANALYSIS 92
- 16.1.4 PRODUCT PORTFOLIO 92
- 16.1.5 RECENT DEVELOPMENT 92
16.2 PERKINELMER INC. 93
- 16.2.1 COMPANY SNAPSHOT 93
- 16.2.2 REVENUE ANALYSIS 93
- 16.2.3 COMPANY SHARE ANALYSIS 94
- 16.2.4 PRODUCT PORTFOLIO 94
- 16.2.5 RECENT DEVELOPMENT 94
16.3 FUJIFILM CORPORATION 95
- 16.3.1 COMPANY SNAPSHOT 95
- 16.3.2 REVENUE ANALYSIS 95
- 16.3.3 COMPANY SHARE ANALYSIS 96
- 16.3.4 PRODUCT PORTFOLIO 96
- 16.3.5 RECENT DEVELOPMENT 96
16.4 MILTENYI BIOTEC 97
- 16.4.1 COMPANY SNAPSHOT 97
- 16.4.2 COMPANY SHARE ANALYSIS 97
- 16.4.3 PRODUCT PORTFOLIO 98
- 16.4.4 RECENT DEVELOPMENT 98
16.5 CHARLES RIVER LABORATORIES. 99
- 16.5.1 COMPANY SNAPSHOT 99
- 16.5.2 REVENUE ANALYSIS 99
- 16.5.3 COMPANY SHARE ANALYSIS 100
- 16.5.4 PRODUCT PORTFOLIO 100
- 16.5.5 RECENT DEVELOPMENT 100
16.6 AI4R 101
- 16.6.1 COMPANY SNAPSHOT 101
- 16.6.2 PRODUCT PORTFOLIO 101
- 16.6.3 RECENT DEVELOPMENT 101
16.7 ASPECT IMAGING LTD. 102
- 16.7.1 COMPANY SNAPSHOT 102
- 16.7.2 PRODUCT PORTFOLIO 102
- 16.7.3 RECENT DEVELOPMENT 102
16.8 BERTHOLD TECHNOLOGIES GMBH & CO.KG 103
- 16.8.1 COMPANY SNAPSHOT 103
- 16.8.2 PRODUCT PORTFOLIO 103
- 16.8.3 RECENT DEVELOPMENT 103
16.9 CUBRESA INC. 104
- 16.9.1 COMPANY SNAPSHOT 104
- 16.9.2 PRODUCT PORTFOLIO 104
- 16.9.3 RECENT DEVELOPMENT 104
16.10 HOLOGIC, INC. 105
- 16.10.1 COMPANY SNAPSHOT 105
- 16.10.2 REVENUE ANALYSIS 105
- 16.10.3 PRODUCT PORTFOLIO 106
- 16.10.4 RECENT DEVELOPMENT 106
16.11 LI-COR, INC. 107
- 16.11.1 COMPANY SNAPSHOT 107
- 16.11.2 PRODUCT PORTFOLIO 107
- 16.11.3 RECENT DEVELOPMENT 107
16.12 MEDISO LTD. 108
- 16.12.1 COMPANY SNAPSHOT 108
- 16.12.2 PRODUCT PORTFOLIO 108
- 16.12.3 RECENT DEVELOPMENT 108
16.13 MILABS B.V. 109
- 16.13.1 COMPANY SNAPSHOT 109
- 16.13.2 PRODUCT PORTFOLIO 109
- 16.13.3 RECENT DEVELOPMENT 109
16.14 MR SOLUTIONS 110
- 16.14.1 COMPANY SNAPSHOT 110
- 16.14.2 PRODUCT PORTFOLIO 110
- 16.14.3 RECENT DEVELOPMENT 110
16.15 SPECTRAL INSTRUMENTS IMAGING 111
- 16.15.1 COMPANY SNAPSHOT 111
- 16.15.2 PRODUCT PORTFOLIO 111
- 16.15.3 RECENT DEVELOPMENT 111
16.16 TRIFOIL IMAGING 112
- 16.16.1 COMPANY SNAPSHOT 112
- 16.16.2 PRODUCT PORTFOLIO 112
- 16.16.3 RECENT DEVELOPMENT 112

17 QUESTIONNAIRE 113

18 RELATED REPORTS 116

LIST OF TABLES

TABLE 1 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 48
TABLE 2 NORTH AMERICA MRI IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 48
TABLE 3 NORTH AMERICA PET/SPECT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 49
TABLE 4 NORTH AMERICA CT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 49
TABLE 5 NORTH AMERICA OPTICAL MINISCOPES IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 50
TABLE 6 NORTH AMERICA 2 PHOTON CONFOCAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 50
TABLE 7 NORTH AMERICA US IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 51
TABLE 8 NORTH AMERICA NIR FLUORESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 51
TABLE 9 NORTH AMERICA OCT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 52
TABLE 10 NORTH AMERICA BIOLUMINESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 52
TABLE 11 NORTH AMERICA OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 53
TABLE 12 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 56
TABLE 13 NORTH AMERICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 56
TABLE 14 NORTH AMERICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 56
TABLE 15 NORTH AMERICA DISEASE CHARACTERIZATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 57
TABLE 16 NORTH AMERICA TOXICOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 58
TABLE 17 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 61
TABLE 18 NORTH AMERICA ALZHEIMER'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 61
TABLE 19 NORTH AMERICA PARKINSON'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 62
TABLE 20 NORTH AMERICA ONCOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 62
TABLE 21 NORTH AMERICA OTHER THERAPEUTIC AREAS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 63
TABLE 22 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 66
TABLE 23 NORTH AMERICA BOLD IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 66
TABLE 24 NORTH AMERICA OXYGENATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 67
TABLE 25 NORTH AMERICA BLOOD FLOW IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 67
TABLE 26 NORTH AMERICA MICROVESSELS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
TABLE 27 NORTH AMERICA NEURONAL ACTIVITY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
TABLE 28 NORTH AMERICA SOFT TISSUE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 69
TABLE 29 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 72
TABLE 30 NORTH AMERICA UNDER AN HOUR IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 72
TABLE 31 NORTH AMERICA MANY HOURS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
TABLE 32 NORTH AMERICA LONGITUDINAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
TABLE 33 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 76
TABLE 34 NORTH AMERICA PHARMA-INHOUSE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
TABLE 35 NORTH AMERICA CRO IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 77
TABLE 36 NORTH AMERICA ACADEMIA IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 77
TABLE 37 NORTH AMERICA OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 78
TABLE 38 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 80
TABLE 39 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 80
TABLE 40 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 80
TABLE 41 NORTH AMERICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 81
TABLE 42 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 81
TABLE 43 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 81
TABLE 44 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 81
TABLE 45 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 82
TABLE 46 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 83
TABLE 47 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 83
TABLE 48 U.S. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 83
TABLE 49 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 84
TABLE 50 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 84
TABLE 51 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 84
TABLE 52 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 84
TABLE 53 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 85
TABLE 54 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 85
TABLE 55 CANADA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 85
TABLE 56 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 86
TABLE 57 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 86
TABLE 58 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 86
TABLE 59 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 86
TABLE 60 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 87
TABLE 61 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 87
TABLE 62 MEXICO DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 87
TABLE 63 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 88
TABLE 64 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 88
TABLE 65 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 88
TABLE 66 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 88

LIST OF FIGURES

FIGURE 1 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION 18
FIGURE 2 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DATA TRIANGULATION 21
FIGURE 3 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DROC ANALYSIS 22
FIGURE 4 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 23
FIGURE 5 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY RESEARCH ANALYSIS 23
FIGURE 6 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: INTERVIEW DEMOGRAPHICS 24
FIGURE 7 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: MARKET END USERS COVERAGE GRID 26
FIGURE 8 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DBMR MARKET POSITION GRID 27
FIGURE 9 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: VENDOR SHARE ANALYSIS 29
FIGURE 10 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION 33
FIGURE 11 RISING PREVALENCE OF NEUROLOGICAL DISORDER IS EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET FROM 2023 TO 2030 34
FIGURE 12 IMAGING MODALITY TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET IN 2023 & 2030 34
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET 40
FIGURE 14 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY IMAGING MODALITY TYPE, 2022 47
FIGURE 15 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY APPLICATION, 2022 55
FIGURE 16 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY THERAPEUTIC AREA, 2022 60
FIGURE 17 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY BIOLOGICAL VARIABLE, 2022 65
FIGURE 18 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY TEMPORAL FORMAT OF USE, 2022 71
FIGURE 19 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY END USER, 2022 75
FIGURE 20 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%) 89